Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04787848 · ClinicalTrials.gov registry record · NA
Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics
A NA study of Chronic Widespread Pain, sponsored by Florida International University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04787848: Recruiting NA study of Chronic Widespread Pain, sponsored by Florida International University.
NCT04787848 is a NA study of Chronic Widespread Pain that is actively recruiting participants, run by Florida International University. The registered enrollment target is 200 participants, above the 45-participant average among 4 other Chronic Widespread Pain trials with a reported enrollment target (344% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04787848, a NA study of Chronic Widespread Pain, is actively recruiting participants, sponsored by Florida International University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if decreased production or release of endogenous opioid peptides by peripheral immune cells contributes to hypersensitivity in people with HIV
Primary Outcome
Measured at baseline and 30 min post intervention to assess change in response. (0=no pain, 100=most pain) * Heat Pain - 1) A slowly increasing heat stimulus (44°C, 46°C, and 48°C) will be delivered; 2) a series of 5 heat pulses (about 2 sec) will be given and pain will be rated (0-100) * Touch Test Pain. Von Frey filament will be tapped on knee and hand and asked to rate the pain (0-100) after a single tap, and after 10 consecutive taps * Pressure Pain Threshold. A slowly increasing pressure w
Conditions Studied
Interventions
- DRUG Relistor Injectable Product
Study Locations (1)
Florida
- Ambulatory Care Center, Florida International University - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
What NCT04787848 shows while recruiting
NCT04787848 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 45-participant average among 4 other Chronic Widespread Pain trials with a reported enrollment target (344% higher).
The record links to 1 condition, with Chronic Widespread Pain appearing as the primary indexed condition, and to 1 intervention - of which Relistor Injectable Product is the first listed.
NCT04787848 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04787848 about?
NCT04787848 is a clinical study titled "Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics". To determine if decreased production or release of endogenous opioid peptides by peripheral immune cells contributes to hypersensitivity in people with HIV
What is the current status of trial NCT04787848?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2021-11-15. Estimated completion is 2026-07-30.
What conditions does trial NCT04787848 study?
This clinical trial studies the following conditions: Chronic Widespread Pain.
What interventions are being tested in trial NCT04787848?
The interventions under investigation include: Relistor Injectable Product (DRUG).
Who is sponsoring clinical trial NCT04787848?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04787848 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Widespread Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)
RECRUITING · NA
-
Neurobiological Mechanisms of Stress in Youth With Chronic Widespread Pain
ACTIVE NOT RECRUITING · NA
-
Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study
COMPLETED · NA
-
Two Point Discrimination
ACTIVE NOT RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI